Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
International Journal of Clinical Oncology
|
September 20, 2024
Preliminary results from ASCENT-J02: a phase 1/2 study of sacituzumab govitecan in Japanese patients with advanced solid tumors
Yoichi Naito, Seigo Nakamura, Nobuko Kawaguchi-Sakita, et al.
Leukemia Research Reports
|
August 11, 2017
Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated <i>Fusarium solani</i> infection
Sheenu Sheela, Sawa Ito, Jeffrey R Strich, et al.
Leukemia Research
|
March 27, 2026
Clinical strategies for leukemia management: Recommendations from the Bridging the Gaps in Hematology Oncology Consensus Conference 2025
Hetty E Carraway, Daniel J DeAngelo, Eunice S Wang, et al.
British Journal of Haematology
|
December 17, 2013
Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia
Santosh L Saraf, Xu Zhang, Tamir Kanias, et al.
The Lancet. Oncology
|
April 6, 2015
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
Mark Roschewski, Kieron Dunleavy, Stefania Pittaluga, et al.
The New England Journal of Medicine
|
October 22, 2025
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
Javier Cortés, Kevin Punie, Carlos Barrios, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2019
Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study
Shirish M Gadgeel, Rimas V Lukas, Jerome Goldschmidt, et al.
JCO Oncology Practice
|
June 25, 2025
Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Hope S Rugo, Mina S Sedrak, et al.
Cancer
|
May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
James M Foran, Zhuoxin Sun, Catherine Lai, et al.
Transplantation and Cellular Therapy
|
November 1, 2023
Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation
Lacey S Williams, Kirsten M Williams, Nancy Gillis, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
International Journal of Clinical Oncology
|
September 20, 2024
Preliminary results from ASCENT-J02: a phase 1/2 study of sacituzumab govitecan in Japanese patients with advanced solid tumors
Yoichi Naito, Seigo Nakamura, Nobuko Kawaguchi-Sakita, et al.
Leukemia Research Reports
|
August 11, 2017
Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated <i>Fusarium solani</i> infection
Sheenu Sheela, Sawa Ito, Jeffrey R Strich, et al.
Leukemia Research
|
March 27, 2026
Clinical strategies for leukemia management: Recommendations from the Bridging the Gaps in Hematology Oncology Consensus Conference 2025
Hetty E Carraway, Daniel J DeAngelo, Eunice S Wang, et al.
British Journal of Haematology
|
December 17, 2013
Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia
Santosh L Saraf, Xu Zhang, Tamir Kanias, et al.
The Lancet. Oncology
|
April 6, 2015
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
Mark Roschewski, Kieron Dunleavy, Stefania Pittaluga, et al.
The New England Journal of Medicine
|
October 22, 2025
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
Javier Cortés, Kevin Punie, Carlos Barrios, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2019
Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study
Shirish M Gadgeel, Rimas V Lukas, Jerome Goldschmidt, et al.
JCO Oncology Practice
|
June 25, 2025
Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Hope S Rugo, Mina S Sedrak, et al.
Cancer
|
May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
James M Foran, Zhuoxin Sun, Catherine Lai, et al.
Transplantation and Cellular Therapy
|
November 1, 2023
Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation
Lacey S Williams, Kirsten M Williams, Nancy Gillis, et al.
Page
of 9